Interpatient variability in tamoxifen respone among breast cancer patient: the use of pharmacogenetics and metabolomics in closing the gaps in clinical practice / Nor Izwani Mohamed

Tamoxifen has been widely used as the standard adjuvant therapy for breast cancer patients with oestrogen receptor-positive status, especially in the highrisk pre- and postmenopausal women. However, 30 to 50% of ER-positive breast cancer patients do not respond to tamoxifen therapy. Major challenges...

Full description

Bibliographic Details
Main Author: Mohamed, Nor Izwani
Format: Book Section
Language:English
Published: Institute of Graduate Studies, UiTM 2017
Subjects:
Online Access:http://ir.uitm.edu.my/id/eprint/19903/
http://ir.uitm.edu.my/id/eprint/19903/1/ABS_NOR%20IZWANI%20MOHAMED%20TDRA%20VOL%2012%20IGS%2017.pdf